The Market's True Earnings Expectations

Go beyond the consensus and become a better stock picker with Earnings Whisper numbers, investor sentiment, and proprietary research and tools to help you capture the Post-Earnings Announcement Drift (PEAD) and outperform the overall stock market. Plus, get the most accurate earnings dates, earnings news, and insights into how stocks react before and after earnings.



Most Anticipated Earnings Releases TM

Next Week →

The most anticipated earnings releases for the week beginning September 21, 2026 are COST Costco Wholesale THO THOR Industries ABVX ABIVAX Société Anonyme AZO AutoZone BB BlackBerry

Monday
Sep 21
Tuesday
Sep 22
Wednesday
Sep 23
Thursday
Sep 24
Friday
Sep 25
Before Open
After Close
Before Open
After Close
Before Open
After Close
Before Open
After Close
Before Open
After Close
After the Close, Monday, September 21: ABVX
Before the Open, Tuesday, September 22: THO, AZO, MLKN After the Close, Tuesday, September 22: KBH, WOR, AYTU
Before the Open, Wednesday, September 23: CBRL, GIS, PAYX, CTAS After the Close, Wednesday, September 23: SFIX, FUL, NEOV
Before the Open, Thursday, September 24: BB, DRI, SNX After the Close, Thursday, September 24: COST, SCHL, LGCY
Monday Sep 21
Before the Open
—
After the Close
ABVX reporting after the close on Monday, September 21
Tuesday Sep 22
Before the Open
THO, AZO, MLKN reporting before the open on Tuesday, September 22
After the Close
KBH, WOR, AYTU reporting after the close on Tuesday, September 22
Wednesday Sep 23
Before the Open
CBRL, GIS, PAYX, CTAS reporting before the open on Wednesday, September 23
After the Close
SFIX, FUL, NEOV reporting after the close on Wednesday, September 23
See the full week →

Earnings Whisper® Score

Capturing the Earnings Announcement Premium

The Earnings Whisper Score, from −5 to +5, measures the expectation setup ahead of a report. From Apr 2014 – Sep 2026, +5 Scores averaged +1.08% into earnings while −5 stocks averaged −0.27% — a 135-basis-point spread.

+1.08% +5 Score 11,380 events
+0.47% All others 121,945 events
+0.26% Neutral 18,046 events
−0.27% −5 Score 3,787 events

Average return, one week before the report through the open following the announcement.

−0.40% −0.20% 0.00% +0.20% +0.40% +0.60% +0.80% +1.00% +1.20% 1st Day 2nd Day 3rd Day 4th Day Gap +5 Scores All Others Neutral Scores −5 Scores
Cumulative average return by Earnings Whisper Score, Apr 2014 – Sep 2026.
Read the research

The Whisper Report®

See all

The Fed Test

Monday, September 14, 2026
A Fed hike is not necessarily bearish if productivity and earnings stay strong. For now, JNK and SPY support need to hold.
LEN TCOM EMAT ORCL SIG AEO
Read Report

Earnings Preview

COST Costco Wholesale is confirmed to report Thursday, September 24, after the close.

Costco's Margin Trade-Off Faces Its Next Test as Stock Slides Below Its 200-Day Average

Costco heads into its fiscal fourth-quarter report carrying one of the more interesting tensions in retail right now: sales momentum has been accelerating for four straight quarters, yet the stock has fallen 8.6 percent since the last print while the S&P 500 gained slightly. That divergence is the central puzzle investors need this report to resolve.

Wall Street expects EPS of $6.48 on revenue of $94.78 billion, representing roughly 10 percent growth on both lines. The Earnings Whisper number sits marginally higher at $6.54, suggesting the bar is not dramatically elevated but skews slightly optimistic. Costco does not issue formal guidance, so the real benchmark is the trajectory management laid out last quarter, when net sales growth hit 11.6 percent, the fastest of the past four quarters, powered by record-breaking gasoline volumes and comps ex-gas and FX holding near 6.6 percent. If that pace decelerates meaningfully from Q3 levels, it would be the first crack in an otherwise strengthening demand story.

Continue reading →

Top Earnings News

See all

The recent, most closely watched, earnings results.

Innate Pharma S.A. Reported Earnings
Thursday, September 17, 2026 at 1:00 AM
Innate Pharma S.A. (IPHA) reported a loss of $0.24 per share on for the second quarter ended June 2026. .

Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.

The Drift

Read more
Upcoming Earnings

Earnings Week Ahead: Retail Giants and Sleepy Staples Take Center Stage

September 19, 2026
COST CBRL BB DRI GIS THO
This week's earnings parade is heavy on the names that hit close to home, from the warehouse aisles of Costco to the dinner tables served by Darden and General Mills. Costco remains the marquee draw, and while the crowd loves the story, the mood heading in is surprisingly cautious given how much the stock has cooled since its last report. AutoZone and cleaning-and-uniforms powerhouse Cintas round out a strong showing from the everyday-economy crowd, both riding solid operational momentum even as traders temper their enthusiasm. The wild card is Cracker Barrel, which has quietly become one of the more optimistic setups on the calendar after a rough stretch, so keep an eye on whether the old country store can serve up a surprise. History suggests these stocks tend to swing more than a percent or two when the numbers hit, so buckle up.
Continue reading →

Recent Positive Earnings

HIPO -2.4% since the report




Trusted Earnings Research Since 1998

For more than 25 years, investors and financial professionals have used Earnings Whispers to look beyond consensus estimates and better understand the expectations driving stock prices around earnings.

Learn more about Earnings Whispers